These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 30005674)

  • 21. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
    Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
    Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: An observational study.
    Zanichelli A; Ghezzi M; Santicchia I; Vacchini R; Cicardi M; Sparaco A; Donati G; Ranìa V; Busa A
    PLoS One; 2020; 15(3):e0230128. PubMed ID: 32163480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
    Bork K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study.
    Anderson J; Soteres D; Mellor J; Connolly H; Wynne-Cattanach K; Earl L; Schultz BG; Juethner S
    Allergy Asthma Proc; 2024 Jul; 45(4):247-254. PubMed ID: 38982603
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy.
    Zanichelli A; Arcoleo F; Barca MP; Borrelli P; Bova M; Cancian M; Cicardi M; Cillari E; De Carolis C; De Pasquale T; Del Corso I; Di Rocco PC; Guarino MD; Massaro I; Minale P; Montinaro V; Neri S; Perricone R; Pucci S; Quattrocchi P; Rossi O; Triggiani M; Zanierato G; Zoli A
    Orphanet J Rare Dis; 2015 Feb; 10():11. PubMed ID: 25758562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HEREDITARY ANGIOEDEMA DUE TO C1-INHIBITOR DEFICIENCY IN PEDIATRIC PATIENTS IN CROATIA - FIRST NATIONAL STUDY, DIAGNOSTIC AND PROPHYLACTIC CHALLENGES.
    Karadža-Lapić L; Barešić M; Vrsalović R; Ivković-Jureković I; Sršen S; Prkačin I; Rijavec M; Cikojević D
    Acta Clin Croat; 2019 Mar; 58(1):139-146. PubMed ID: 31363336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HAE-AS: A Specific Disease Activity Scale for Hereditary Angioedema With C1-Inhibitor Deficiency.
    Forjaz MJ; Ayala A; Caminoa M; Prior N; Pérez-Fernández E; Caballero T;
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):246-252. PubMed ID: 31932270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
    Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
    Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.
    Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L
    Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.
    Andrási N; Veszeli N; Holdonner Á; Temesszentandrási G; Kőhalmi KV; Varga L; Farkas H
    Int Immunopharmacol; 2020 Mar; 80():106216. PubMed ID: 31982824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parameters of the classical complement pathway predict disease severity in hereditary angioedema.
    Csuka D; Füst G; Farkas H; Varga L
    Clin Immunol; 2011 Apr; 139(1):85-93. PubMed ID: 21300570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.
    Loffredo S; Bova M; Suffritti C; Borriello F; Zanichelli A; Petraroli A; Varricchi G; Triggiani M; Cicardi M; Marone G
    Allergy; 2016 Jul; 71(7):989-96. PubMed ID: 26873113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.
    Moreno AS; Valle SO; Levy S; França AT; Serpa FS; Arcuri HA; Palma MS; Campos WN; Dias MM; Ponard D; Monnier N; Lunardi J; Bork K; Silva WA; Arruda LK
    Int Arch Allergy Immunol; 2015; 166(2):114-20. PubMed ID: 25790805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary and acquired angioedema.
    Patel G; Pongracic JA
    Allergy Asthma Proc; 2019 Nov; 40(6):441-445. PubMed ID: 31690390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
    Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
    Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.
    Kajdácsi E; Jandrasics Z; Veszeli N; Makó V; Koncz A; Gulyás D; Köhalmi KV; Temesszentandrási G; Cervenak L; Gál P; Dobó J; de Maat S; Maas C; Farkas H; Varga L
    Front Immunol; 2020; 11():794. PubMed ID: 32431708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.